INFECTIOUS DISEASES

这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金， 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 美国和墨西哥边境沿线的地区是发展中国家和发达国家交汇的边界线，几乎在生活的方方面面都产生了独特的混合环境。这一地区是一个大熔炉，将边界两侧对人类健康的独特挑战合并为一个双重危险的地区，人口面临着两种环境弊病的风险。埃尔帕索高于正常水平的脑囊虫病和耐药结核病的发病率是这种并存的结果的两个例子。西德克萨斯沙漠地区的日益发展加剧了这一问题，使越来越多的人频繁接触新环境，增加了新疾病传播的机会。由于这些担忧，德克萨斯大学埃尔帕索分校的边境生物医学研究中心设立了一个专门的传染病研究单位，以促进具有区域重要性的传染病病原体研究计划的发展。除了继续支持现有的研究计划外，这项提议还将为新的BSL3实验室研究设施提供设备和工作人员支持，该实验室研究设施包括在UTEP的新生物科学研究大楼内。这一安全设施将使研究计划集中于更高水平的感染性病原体，特别是耐药结核分枝杆菌。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The region along the Border between the United States and Mexico is a boundary called ¿la frontera¿ where developing and developed worlds meet, resulting in a unique, hybrid environment in nearly every aspect of life. This area is a melting pot, combining the unique challenges to human health from each side of the border into a region of double jeopardy, with the population at risk from the ills of both environments. The higher than normal rates in El Paso of neurocystercercosis and drug resistant TB are two examples of the result of this juxtaposition. The increased development of the desert regions of West Texas exacerbate this problem, bringing increasing numbers of people into frequent contact with new environments, enhancing the opportunity for the spread of new diseases. Because of these concerns, the Border Biomedical Research Center at the University of Texas at El Paso includes a specific research unit in Infectious Diseases to foster the development of research programs on infectious agents of regional importance. In addition to continuing support of existing research programs, this proposal equipment and staff support infrastructure for a new BSL3 laboratory research facility included in the new Biosciences Research Building at UTEP. This secure facility will enable development of research programs focussing on higher level infectious agents, in particular drug resistant Mycobacterium tuberculo